Install
Log in to Yicai Global We sent you a code You'll need a password Find your Yicai Global account
- 28articles · 30d
- 3+ day agolatest article
- Aug 23, 2026earliest in window
- 96%with images
- 341avg words
- Economy, Business & Finance 21
- Finance & Business 14
- News 13
- Science & Nature 5
- Business & Industrial 3
- Medical 3
- Science & Technology 3
- Finance 2
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
China’s Simnova Bags USD59.5 Million in New Funding to Advance Off-the-Shelf Cell Therapies
1+ week, 4+ hour ago (297+ words) (Yicai) Aug. 31 -- Simnova Biotech has secured nearly CNY400 million (USD59.5 million) in its latest funding round to accelerate clinical research of the Chinese cell therapy startup’s off-the-shelf cell therapies, the firm said today. The Series B funding round was co-led by Shanghai…...
China’s Akeso Jumps After Study Shows New Drug-Chemo Combo Beats Other BTC Therapies
1+ week, 4+ day ago (327+ words) (Yicai) Aug. 26 -- Akeso’s shares climbed after the Chinese drugmaker said results from the Phase III clinical trial of its innovative drug ivonescimab in combination with chemotherapy showed it outperformed other global first‑line treatments for advanced biliary tract cancer. Akeso…...
BeOne Medicines Agrees to Cut Price of Esophageal Cancer Drug in US
1+ week, 5+ day ago (363+ words) (Yicai) Sept. 1 -- Oncology company BeOne Medicines has agreed to reduce the price of Tevimbra, an innovative oral anticancer drug used to treat various types of esophageal carcinoma, under the Medicaid healthcare program in the United States. Medicaid is designed for…...